How to safely taper a patient off Wellbutrin (bupropion) 150mg SR?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Safe Tapering Protocol for Wellbutrin (Bupropion) 150mg SR

The safest approach to tapering Wellbutrin 150mg SR is to reduce the dose to 150mg every other day for 1-2 weeks before discontinuation, as recommended in the FDA drug label. 1

General Tapering Principles

  • Gradual tapering is necessary for most antidepressants to minimize discontinuation symptoms, which can be both somatic and psychological in nature 2
  • A collaborative approach between provider and patient increases success rates, including discussing expectations, potential withdrawal symptoms, and contingency plans 3
  • Clear communication that the provider is not abandoning the patient but helping them safely discontinue medication is essential 3

Specific Tapering Protocol for Wellbutrin 150mg SR

Step 1: Initial Assessment

  • Assess for depression, anxiety, and insomnia before beginning the taper, as these conditions should be addressed before proceeding 3
  • Screen for substance use disorders, as patients with these conditions may have difficulty tolerating medication discontinuation 3

Step 2: Tapering Schedule

  • For Wellbutrin 150mg SR, the FDA-approved approach is to decrease to 150mg every other day prior to discontinuation 1
  • The taper should last 1-2 weeks at minimum, though patients on long-term therapy may benefit from a slower taper 3
  • For patients who have been taking Wellbutrin for a year or longer, consider an even slower taper of 10% per month to minimize withdrawal symptoms 4

Step 3: Monitoring and Management of Withdrawal Symptoms

  • Common withdrawal symptoms may include headache, irritability, anxiety, and insomnia, which are generally transient 5
  • For mild symptoms, reassurance that these symptoms are usually temporary is often sufficient 2
  • For more severe symptoms, consider temporarily returning to the previous dose and then resuming tapering at a slower rate 4

Special Considerations

  • Patients with hepatic impairment may require even more gradual tapering due to altered drug metabolism 1
  • Consider adjunctive treatments for specific withdrawal symptoms as needed (e.g., sleep aids for insomnia) 4
  • Cognitive behavioral therapy may increase tapering success rates and could be particularly helpful for patients struggling with discontinuation 6

Common Pitfalls to Avoid

  • Avoid abrupt discontinuation, which increases the risk of withdrawal symptoms 2
  • Don't mistake withdrawal symptoms for recurrence of the original condition, which could lead to unnecessary reinstatement of the medication 2
  • Avoid tapering too quickly in patients with a history of difficult medication discontinuation 4
  • Remember that the target dose may not necessarily be zero; some patients may benefit from continuing at a lower maintenance dose 4

Follow-up Recommendations

  • Follow up frequently (at least monthly) with patients undergoing antidepressant tapering 6
  • Provide clear instructions on when to contact the provider if withdrawal symptoms become severe 3
  • Consider more frequent follow-up for patients with comorbid psychiatric conditions 3

By following this evidence-based tapering protocol, patients can safely discontinue Wellbutrin 150mg SR while minimizing the risk of withdrawal symptoms and ensuring appropriate monitoring throughout the process.

References

Research

Clinical management of antidepressant discontinuation.

The Journal of clinical psychiatry, 1997

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Trazodone Tapering Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Tapering Protocol for Benzodiazepine Discontinuation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.